Ushbu maqolada yoshlarning axloqiy begonalashuvi madaniy
begonalashuvining asosiy omili ekanligi yoritilgan bo‘lib, bu asosan jamiyatdagi xulq-atvor
me'yorlarini chetlab o‘tish, “ommaviy madaniyat” ning ta'siri ostida sodir bo‘lishi yoritib berilgan.
MethodsRetrospective analysis of patients from the Swiss Stroke Registry, with admission NIHSS ≤ 5, LVO and treated by EVT (+/-IVT) versus IVT alone. Primary endpoint was favorable functional outcome (modified Rankin Scale [mRS] 0-1) at 3 months. Secondary outcomes were independence (mRS 0-2), mRS (ordinal shift analysis) and survival with high disability (mRS 4-5). Safety endpoints were mortality and symptomatic hemorrhage.
In this case series we assessed feasibility and safety of DCB-PTA in patients with high-grade OVAS using Neuro Elutax S V ( A a c h e n Resonance, Aachen, Germany) and SeQuent Please NEO (B.Braun,
for the BIOSIGNAL investigators Methods • In this prospective, multicenter cohort study (2014)(2015)(2016)(2017) we measured MR-pro ANP in ischemic stroke patients within 24h of symptoms onset. (By a sandwich immunoassay (BRAHMS AG, Berlin). • Univariate and multivariate logistic regression models were fitted to estimate odds ratios for the magnitude and independence of the association of MR-proANP with each outcome measure.
Background• The use of rapidly measurable blood biomarkers may advance the identification of patients with underlying atrial cardiopathy, who may benefit more from direct oral anticoagulants compared to antiplatelets for secondary prevention. • The objective of this study was to assess the incremental value of midregional pro-Atrial Natriuretic Peptide (MR-proANP) in identifying cardio-embolic stroke (CE stroke according to the TOAST criteria), newly diagnosed atrial fibrillation (AF) during hospitalization and on follow-up as well as recurrent vascular events after ischemic stroke.
ResultsConclusions MR-proANP is an independent marker for cardio-embolic stroke etiology according to the TOAST criteria, newly detected atrial fibrillation and cardiovascular events up to one year after the index stroke. Therefore MR-proANP seems to be a good candidate to select patients for prolonged rhythm monitoring in clinical routine or even for oral anticoagulation in a randomized controlled trial.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.